1,5-distributed pyrrolid-2-one derivatives for use as EP4 receptor agonists in the teatment of eye diseases such as glaucoma
Details for Australian Patent Application No. 2003233729 (hide)
International Classifications
Event Publications
28 August 2003 Complete Application Filed
Priority application(s): 60/386,499 06.06.02 US; 60/460,134 03.04.03 US
19 February 2004 Application Open to Public Inspection
Published as AU-B-2003233729
16 March 2006 Assignment before Grant
Merck Frosst Canada & Co. The application has been assigned to Merck Frosst Canada Ltd.
4 October 2007 Application Accepted
Published as AU-B-2003233729
31 January 2008 Standard Patent Sealed
20 March 2008 Amendment Made
The nature of the amendment is: Amend the invention title to read 1,5-distributed pyrrolid-2-one derivatives for use as EP4 receptor agonists in the treatment of eye diseases such as glaucoma 2003235466 CV Therapeutics, Inc. The nature of the amendment is as shown in the statement(s) filed 15 Oct 2007
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003233730-STACKED PLATE HEAT EXCHANGER
2003233728-SYSTEM AND METHOD FOR INJECTING INK INTO AN APPLICATION
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser